These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 6233938

  • 1. [Anti-tumor activity of peripheral lymphocytes of tumor-bearing rats by in vitro culture].
    Horie K, Yamasaki T, Nishimura K, Tsuchiya S, Yoshizawa A, Akimoto R, Watanabe H, Shirasawa K, Suzuki M, Tsujimoto Y.
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1269-75. PubMed ID: 6233938
    [Abstract] [Full Text] [Related]

  • 2. [A basic study on the anti-tumor activity of peripheral lymphocytes of tumor-bearing rats by in vitro culture].
    Horie K.
    Nihon Geka Gakkai Zasshi; 1985 Jul; 86(7):787-801. PubMed ID: 2931583
    [Abstract] [Full Text] [Related]

  • 3. [Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice and rats].
    Ogura T.
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):689-96. PubMed ID: 3083782
    [Abstract] [Full Text] [Related]

  • 4. Rejection of syngeneic tumor cells by the interaction of Lyt-1+ T lymphocytes and macrophages.
    Mitani M, Matsumoto T, Mori K, Miake S, Himeno K, Nomoto K.
    J Clin Lab Immunol; 1985 Oct; 18(2):97-101. PubMed ID: 3935795
    [Abstract] [Full Text] [Related]

  • 5. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
    Kimura H, Yamaguchi Y, Kadoyama C, Sato N, Fujisawa T.
    Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Studies on the suppression of a one-way mixed lymphocyte reaction by mitomycin-C treated responder cells.
    Victorino RM, Hodgson HJ.
    Immunology; 1980 Jul; 40(3):447-53. PubMed ID: 6448802
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Gender dimorphism of macrophage response to GMCSF and IL-4 for differentiation into dendritic cells.
    Gupta V, Singh SM.
    Am J Reprod Immunol; 2008 Jul; 60(1):43-54. PubMed ID: 18593437
    [Abstract] [Full Text] [Related]

  • 14. [Changes of T lymphocyte subsets in BERH-2 hepatoma-bearing rats and effect of different immunotherapies on the tumor].
    Guo YJ.
    Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):168-71. PubMed ID: 2482158
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Potent effector function of tumor-sensitized L-selectin(low) T cells against subcutaneous tumors requires LFA-1 co-stimulation.
    Seeley BM, Barthel SW, To WC, Kjaergaard J, Shu S, Plautz GE.
    Otolaryngol Head Neck Surg; 2001 Apr; 124(4):436-41. PubMed ID: 11283503
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.